Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 44 Issue 11, November 2012

Cover Art: Pine plank 1 by Bryan Nash Gill from Woodcut (Princeton Architectural Press, New York, 2012) http://www.bryannashgill.com/

Editorial

  • Industry and its regulators are increasingly finding value in inviting independent scrutiny of clinical trial data at the participant level. In addition to increasing accuracy and trust, accessible trial data can be used to generate new research hypotheses and validate existing research. Academic trial investigators need to be incentivized to catch up with this encouraging trend.

    Editorial

    Advertisement

Top of page ⤴

News & Views

  • Cellular transformation in cancer has long been associated with aberrant DNA methylation, most notably, hypermethylation of promoter sequences. A new study uses a clever approach of selective high-resolution profiling to follow DNA methylation over a time course of cellular transformation and challenges the notion that hypermethylation in cancer arises in an orchestrated fashion.

    • Arnaud R Krebs
    • Dirk Schübeler
    News & Views
  • Three papers characterizing human germline mutation rates bolster evidence for a relatively low rate of base substitution in modern humans and highlight a central role for paternal age in determining rates of mutation. These studies represent the advent of a transformation in our understanding of mutation rates and processes, which may ultimately have public health implications.

    • Matthew Hurles
    News & Views
  • Many SNPs associated with human disease are located in non-coding regions of the genome. A new study shows that SNPs associated with breast cancer risk are located in enhancer regions and alter binding affinity for the pioneer factor FOXA1.

    • Kerstin B Meyer
    • Jason S Carroll
    News & Views
Top of page ⤴

Research Highlights

Top of page ⤴

Brief Communication

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Search

Quick links